Medpace Stock: Cancellations Are Normalizing (NASDAQ:MEDP)

seekingalpha.com · 2026-07-25

Medpace Holdings demonstrates strong Q2 2026 net new business awards, with a 1.13x net book-to-bill and $3.0B backlog. Learn why MEDP stock is a buy.